期刊文献+

糖尿病防治的策略转变——从关注糖化血红蛋白到着眼心血管事件 被引量:1

The Changes of Strategy in Diabetes——from Focus on Glycosylated Hemoglobin to Avoiding Cardiovascular Events
下载PDF
导出
摘要 通过对2型糖尿病心血管终点事件的观察,更多的临床证据提示,糖尿病的治疗目标应该以减少心血管事件为主。糖尿病防治从策略上发生了两个转变,即以血糖为中心转向以防治心血管事件为中心的多危险因素综合防治策略;以糖化血红蛋白检测作为血糖评价的金标准转向以血糖量、质、时程控制的全面评价策略。 Several recent trials have led to contradictory outcomes in relation to the issue of glycemic control and cardiovascular complications in patients with Type Ⅱ diabetes. The major target of diabetes treatment is to reduce cardiovascular events. Only relying on the glycosylated hemoglobin as the "gold standard" of the maintenance of tight glycemic control should be changed. A multi-- pronged approach to address the total cardiovascular risk factors is imperative. The best practice model for glycemic goals should include the quantity, quality and time course of glycemic exposure.
出处 《医学与哲学(B)》 2009年第4期4-7,共4页 Medicine & Philosophy(B)
关键词 糖尿病 糖化血红蛋白 心血管事件 危险因素 策略转变 diabetes, glycosylated hemoglobin, cardiovascular events, total risk factors, strategies changes
  • 相关文献

参考文献10

  • 1The Actionto Control Cardiovacular Riskin Diabetes Study Group.Effects of intensive glucose loweringin type2diabetes[].The New England Journal of Medicine.2008
  • 2Bell D S,O’Keefe J H,Jellinger P.Postprandial dysmetabolism:the missing link between diabetes and cardiovascular events-[].Endocrine Practice.2008
  • 3Dossett L A,Cao H,Mowery N T,et al.Blood glucose variability is associated with mortality in the surgical intensive care unit[].AmSurg.2008
  • 4Monteiro Silvia.Magnitude of glycaemia variation:a newrisk tool in acute coronary syndromes[R/OL]. http://spo.escardio.org/eSlides/presenter.aspx-eevtid=24&letter=M . 2009
  • 5The Diabetes Control and Complications Trial Research Group.The effect of intensive treatment of diabetes on development and progression of long term complications in insulin dependent diabetes mellitus[].New England Journal of Homeopathy.1993
  • 6UK Prospective Diabetes Study (UKPDS) Group.Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complication in patients with type 2 diabetes (UKPDS 33)[].The Lancet.1998
  • 7Haffner SM,Lehto S,Ronnemaa T,et al.Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction[].New England Journal of Homeopathy.1998
  • 8Gaede P,Vedel P,Larsen N,et al.Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes[].The New England Journal of Medicine.2003
  • 9Colhoun HM,Betteridge DJ,Durrington PN,et al.Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial[].The Lancet.2004
  • 10Cryer PE,Davis SN,Shamoon H.Hypoglycemia in diabetes[].Diabetes Care.2003

同被引文献12

  • 1金文胜,潘长玉,陆菊明,智光,杨波.血糖与动脉粥样硬化的相关研究[J].中华糖尿病杂志(1006-6187),2005,13(1):19-22. 被引量:65
  • 2米树华,陶红,赵全明,田磊,王南晔,郑虹.冠心病合并代谢综合征患者的临床特征与冠状动脉病变程度的关系[J].中华全科医师杂志,2005,4(4):222-225. 被引量:15
  • 3范泉,郭文怡,贾国良.冠心病患者糖化血红蛋白水平与冠状动脉病变的相关性[J].第四军医大学学报,2006,27(8):698-700. 被引量:76
  • 4张磊,王岩,齐秀英.2型糖尿病合并冠心病的危险因素的配对病例对照研究[J].中国糖尿病杂志,2007,15(8):501-502. 被引量:9
  • 5Zoungas S, Patel A, Chalmers J, et al. Severe hypoglycemiaan Risks of vascular event sanddeath[J]. N Engl J Med, 2010, 363 ( 15 ):1410.
  • 6Bonds D E, Miller M E, Bergenstal R M, et al. The association be- tween symptomatic, sever ehypoglycaemia and mortality in type2 diabetes:retrospective epidemiological analysis of the ACCORD study[J]. British Med J, 2010, 340(7 ) :4909.
  • 7Duckworth W, Abraira C, Moritz T, et al. Glucose control and Vas cular complications in veteran- s with type2 diabetes[J]. Nengl J Med, 2009, 360(2 ): 129.
  • 8Desouza C, Salazar H, Cheong B, et al. Association of hypoglycemia and cardiac ischemia:a study based on continuous monitoning [J]. Diabetes Care, 2003, 26 (5):1485.
  • 9Fisman E, Tenenbaum A, Benderly C, et al. Antihgperglenmic Lreatment in diabetics with coronary disease increased metformin associated mortality over 5-year follow up[J]. Cardiology, 1999, 91 (3):195.
  • 10UK Prospective Diabetes Study (UKPDS) Group. Intensive blood- glu-cos econtrol with sulphonylmas or insul incompared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33 )[J]. Lancet, 1998,352(9131 ) : 837.

引证文献1

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部